<DOC>
	<DOCNO>NCT00141453</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety olmesartan versus placebo progression diabetic renal disease .</brief_summary>
	<brief_title>ORIENT : Olmesartan Reducing Incidence End Stage Renal Disease Diabetic Nephropathy Trial</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<criteria>clinical diagnosis diabetic nephropathy patient type 2 diabetes albumintocreatinine ratio &gt; = 300 mg/g creatinine first morning urinalysis serum creatinine 1.0 2.5 mg/dL woman 1.2 2.5 mg/dL men type 1 diabetes nondiabetic nephropathy history myocardial infarction history cardiac bypass graft within 3 month history percutaneous coronary intervention ( PCI ) within 6 month history carotid artery peripheral artery revascularization within 6 month stroke transient ischemic attack ( TIA ) within 1 year unstable angina pectoris heart failure NYHA functional class III IV rapid progression kidney disease within 3 month severe orthostatic hypotension serum potassium level = &lt; 3.5 mEq ( mmol ) /L = &gt; 5.5 mEq ( mmol ) L history rapid elevation serum creatinine level start treatment AII receptor antagonist ACE inhibitor poor glycemic control : HbA1c level = &gt; 11 % history myocardial infarction ( MI ) coronary artery bypass grafting ( CABG ) within 3 month</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>angiotensin II type I receptor blocker</keyword>
	<keyword>diabetic nephropathy</keyword>
	<keyword>end-stage renal disease</keyword>
	<keyword>renal failure</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>olmesartan medoxomil</keyword>
</DOC>